Zevra Therapeutics
Corinna Wetzel is an experienced professional in product development, currently serving as Senior Director of Product Development at Zevra Therapeutics since April 2016, after a progression from Director of Product Development. With a strong background from Nephron Pharmaceuticals and ChemCon GmbH, Corinna excels in managing technology transfer projects, regulatory submissions, and CMC documentation. Corinna Wetzel has extensive expertise in the development of manufacturing processes for sterile ophthalmic, inhalation, and injectable products, along with a solid foundation in medicinal chemistry and organic/organometallic chemistry, demonstrated through research roles at Heinrich-Heine University Düsseldorf. Corinna Wetzel holds a PhD in Medicinal and Pharmaceutical Chemistry and a Diploma in the same field.
This person is not in any teams
This person is not in any offices
Zevra Therapeutics
1 followers
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients. Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.